Mangoceuticals (MGRX) Liabilities and Shareholders Equity (2022 - 2026)
Mangoceuticals recorded quarterly Liabilities and Shareholders Equity of $14.4 million in Q1 2026, down 10.2% quarter-over-quarter from $16.1 million in Q4 2025, and down 33.58% year-over-year from $21.8 million in Q1 2025.
Mangoceuticals' Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $14.4 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 33.58% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $67.9 million (up 1.13% YoY), while the FY2025 annual figure was $16.1 million, up 4.68% from the prior year.
- Liabilities and Shareholders Equity came in at $14.4 million for Q1 2026 at Mangoceuticals, down from $16.1 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $21.8 million in Q1 2025 to a low of $301447.0 in Q1 2024.
- A 5-year average of $10.5 million and a median of $14.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity plunged 92.67% in 2024 and surged 7116.48% in 2025, its largest moves.
- Mangoceuticals' Liabilities and Shareholders Equity stood at $1.0 million in 2022, then grew by 4.74% to $1.1 million in 2023, then jumped by 1362.75% to $15.4 million in 2024, then climbed by 4.68% to $16.1 million in 2025, then dropped by 10.2% to $14.4 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $14.4 million, $16.1 million, and $16.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 8.98 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 728.77 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 1.12 Bn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 5.84 Bn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 1.02 Bn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.42 Bn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.00 Bn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | 14.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.45 Mn |
| Dec 31, 2025 | 16.09 Mn |
| Sep 30, 2025 | 16.53 Mn |
| Jun 30, 2025 | 20.84 Mn |
| Mar 31, 2025 | 21.75 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Sep 30, 2024 | 14.79 Mn |
| Jun 30, 2024 | 15.24 Mn |
| Mar 31, 2024 | 301,447.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 4.12 Mn |
| Dec 31, 2022 | 1.00 Mn |